BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+9.42%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.21B
AUM Growth
+$243M
(+6.1%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108
Top Buys
| 1 |
Netflix
NFLX
|
+$23.5M |
| 2 |
IBM
IBM
|
+$20.5M |
| 3 |
AbbVie
ABBV
|
+$20.4M |
| 4 |
Advanced Micro Devices
AMD
|
+$20.4M |
| 5 |
Palantir
PLTR
|
+$20.3M |
Top Sells
| 1 |
TTM Technologies
TTMI
|
+$19.8M |
| 2 |
Pfizer
PFE
|
+$19.1M |
| 3 |
Qualcomm
QCOM
|
+$19.1M |
| 4 |
Comcast
CMCSA
|
+$19.1M |
| 5 |
Intel
INTC
|
+$19.1M |
Sector Composition
| 1 | Financials | 28.39% |
| 2 | Consumer Discretionary | 12.55% |
| 3 | Technology | 11.6% |
| 4 | Industrials | 11.34% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMCC
1026
Old Market Capital Corporation Common Stock
OMCC
$36.1M
| $136K | ﹤0.01% |
24,894
-331
| -1% | -$1.81K |
|
1027
Lineage Cell Therapeutics
LCTX
$283M
| $136K | ﹤0.01% |
150,000
-17,900
| -11% | -$16.2K |
|
1028
PetMed Express
PETS
$56.4M
| $135K | ﹤0.01% |
40,800
+20,000
| +96% | +$66.4K |
|
1029
Sonder
SOND
$21.4M
| $135K | ﹤0.01% |
50,000
| – | – |
|
1030
Acumen Pharmaceuticals
ABOS
$81.8M
| $134K | ﹤0.01% |
115,171
| – | – |
|
1031
inTEST
INTT
$89.2M
| $132K | ﹤0.01% |
18,200
| – | – |
|
1032
Arteris
AIP
$362M
| $130K | ﹤0.01% |
13,600
| – | – |
|
1033
INNOVATE Corp
VATE
$62.4M
| $129K | ﹤0.01% |
25,000
| – | – |
|
1034
Aemetis
AMTX
$135M
| $129K | ﹤0.01% |
51,900
| – | – |
|
1035
VYNE Therapeutics
VYNE
$7.66M
| $127K | ﹤0.01% |
76,958
+25,000
| +48% | +$41.3K |
|
1036
Sera Prognostics
SERA
$118M
| $127K | ﹤0.01% |
45,705
-45,000
| -50% | -$125K |
|
1037
Biomea Fusion
BMEA
$110M
| $127K | ﹤0.01% |
70,300
+35,000
| +99% | +$63K |
|
1038
Butterfly Network
BFLY
$378M
| $126K | ﹤0.01% |
63,000
-35,000
| -36% | -$70K |
|
1039
Transact Technologies
TACT
$46.9M
| $126K | ﹤0.01% |
34,845
| – | – |
|
1040
RAPT Therapeutics
RAPT
$232M
| $125K | ﹤0.01% |
15,625
+3,125
| +25% | +$25K |
|
1041
Marchex
MCHX
$86.6M
| $123K | ﹤0.01% |
56,828
| – | – |
|
1042
United Homes Group
UHG
$249M
| $122K | ﹤0.01% |
42,000
+27,000
| +180% | +$78.3K |
|
1043
Xtant Medical Holdings
XTNT
$80.8M
| $121K | ﹤0.01% |
164,100
-25,000
| -13% | -$18.5K |
|
1044
Great Elm Group
GEG
$82.6M
| $119K | ﹤0.01% |
56,545
| – | – |
|
1045
Alto Neuroscience
ANRO
$96.7M
| $119K | ﹤0.01% |
54,100
+25,000
| +86% | +$55K |
|
1046
a.k.a. Brands
AKA
$114M
| $118K | ﹤0.01% |
+11,475
| New | +$118K |
|
|
SVCO
1047
Silvaco Group
SVCO
$154M
| $118K | ﹤0.01% |
+25,000
| New | +$118K |
|
1048
Northern Technologies International Corp
NTIC
$74.9M
| $116K | ﹤0.01% |
15,661
| – | – |
|
1049
Coffee Holding Co
JVA
$23.7M
| $116K | ﹤0.01% |
26,758
+3,389
| +15% | +$14.7K |
|
1050
Ventyx Biosciences
VTYX
$170M
| $115K | ﹤0.01% |
53,600
-45,000
| -46% | -$96.3K |
|